How NCRIS infrastructure helped UQ’s vaccine platform – a billion-dollar success
16 December 2025 A landmark deal has placed Australian vaccine innovation on the world stage, with leading healthcare company Sanofi completing the acquisition of Vicebio Molecular Clamp inventors Prof Keith Chappell, Prof Daniel Watterson and Em Prof Paul Young (Photo credit: The University of Queensland ) Vicebio was formed in 2019 to advance The University […]
National Biologics Facility
The National Biologics Facility (NBF) enables Australian researchers to identify and translate their biomedical research discoveries, bridging the gap between early-stage development, testing and clinical supply for next-gen therapeutic candidates. NBF is a Contract Research Organisation that for over 15 years has offered Australian researchers custom manufacturing solutions under phase-appropriate quality systems. Read more about […]